We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Celator® Pharmaceuticals Raises $32.5 Million Completing a $39.3 Million Private Placement Financing

News   May 01, 2013

 
Celator® Pharmaceuticals Raises $32.5 Million Completing a $39.3 Million Private Placement Financing
 
 
 

RELATED ARTICLES

Gene Therapy Restores Immunity in Infants With Rare Immunodeficiency Disease

News

A small clinical trial has shown that gene therapy can safely correct the immune systems of infants newly diagnosed with a rare, life-threatening inherited disorder in which infection-fighting immune cells do not develop or function normally.

READ MORE

Guarding Against Cancer

News

Researchers from the University of Dundee have shown that a drug previously used to treat Type II diabetes could potentially be used to protect against cancer.

READ MORE

Cervical Cancer More Aggressive When HPV Is Not Detected

News

Cervical cancer negative for the human papilloma virus is rare but more aggressive: it is more frequently diagnosed at advanced stages, with more metastasis and reduced survival.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE